JPH0133447B2 - - Google Patents

Info

Publication number
JPH0133447B2
JPH0133447B2 JP61088248A JP8824886A JPH0133447B2 JP H0133447 B2 JPH0133447 B2 JP H0133447B2 JP 61088248 A JP61088248 A JP 61088248A JP 8824886 A JP8824886 A JP 8824886A JP H0133447 B2 JPH0133447 B2 JP H0133447B2
Authority
JP
Japan
Prior art keywords
kasugamycin
yellowtail
diseases
bacteria
control agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP61088248A
Other languages
Japanese (ja)
Other versions
JPS61275219A (en
Inventor
Hiroshi Okamoto
Masayuki Matsuoka
Kaoru Ishizuka
Hamao Umezawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hokko Chemical Industry Co Ltd
Original Assignee
Hokko Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokko Chemical Industry Co Ltd filed Critical Hokko Chemical Industry Co Ltd
Priority to JP8824886A priority Critical patent/JPS61275219A/en
Publication of JPS61275219A publication Critical patent/JPS61275219A/en
Publication of JPH0133447B2 publication Critical patent/JPH0133447B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は、カスガマイシンまたはその塩類(た
とえば塩酸塩;以下これらをカスガマイシンとい
う)を有効成分として含有することを特徴とする
ハマチの細菌性疾病防除剤に関する。 カスガマイシンは、ストレプトミセス・カスガ
エンシスと命名された放線菌の生産する抗生物質
であり、(特公昭42−6818号公報)、イネいもち病
に対し特効的な治療効果を有しているため、農業
用殺菌剤として実用化されている。 本発明者らは、ハマチに発生する疾病に対し有
効な薬剤を開発する目的で種々の薬剤についてス
クリーニングを行つた。その結果、カスガマイシ
ンがビブリオ菌によるビブリオ病、パスツウレラ
菌による類結節症などに極めて有効であることを
見出した。本発明によれば、カスガマイシンを使
用してこれら細菌によるハマチの疾病を経済的に
且つハマチに薬害を与えることなく完治する方法
が提供される。 ハマチは、重要な蛋白資源であるために、近年
天然資源保護の見地より自然魚法と併用して養殖
魚法が漸次盛んになつてきている。しかしなが
ら、養殖魚法の場合は、限られた面積内で比較的
多数の個体を飼養するために、各種の疾病に患り
やすい。このため、これらの疾病を対象として
種々の抗生物質を含む抗菌剤が使用されている
が、これらの中には人の疾病にも使用されるもの
が含まれており、耐性菌の問題などを考えると必
ずしも好ましくない。 カスガマイシンは、イネいもち病防除剤として
開発された薬剤で、現在イネいもち病防除剤とし
て広く使用されており、その毒性は極めて低く、
慢性毒性も認められない。またカスガマイシン
は、動物体内では比較的速かに排泄され、自然環
境内においても分解されることが確認されてお
り、極めて安全な薬剤である。 またカスガマイシン塩酸塩のハマチ以外の水産
動物に対する半数致死濃度は、コイ、ワキン、ヒ
メダカ、ドジヨウ、オタマジヤクシ、ミジンコお
よびタマミジンコのいずれに対しても1000ppm以
上であつて、極めて魚毒性が低い。そのために、
比較的高濃度の薬剤処理を行つたとしても、これ
を含む排水等によりこれらの水産動物が汚染され
たり、死亡したりする心配がなく、ハマチに対し
て薬害を与えることなく所期の治療効果を十分に
あげることができる。 一般に行われている寒天希釈法で、ハマチに感
染する細菌に対してカスガマイシンの最低発育阻
止濃度をしらべた。その結果を第1表に示した。
The present invention relates to a bacterial disease control agent for yellowtail, which contains kasugamycin or a salt thereof (eg, hydrochloride; hereinafter referred to as kasugamycin) as an active ingredient. Kasugamycin is an antibiotic produced by an actinomycete named Streptomyces kasugaensis (Japanese Patent Publication No. 6818/1983), and has a specific therapeutic effect on rice blast disease, so it is used in agriculture. It has been put into practical use as a disinfectant. The present inventors screened various drugs for the purpose of developing drugs effective against diseases occurring in yellowtail. As a result, it was found that kasugamycin is extremely effective against Vibrio disease caused by Vibrio bacteria and nodularity caused by Pasteurella bacteria. According to the present invention, there is provided a method for completely curing diseases of yellowtail caused by these bacteria using kasugamycin economically and without causing chemical damage to yellowtail. Since yellowtail is an important protein resource, in recent years, farmed fish methods have been gradually gaining popularity in combination with natural fish methods from the viewpoint of natural resource protection. However, in the case of the farmed fish method, because a relatively large number of individuals are raised within a limited area, the fish are susceptible to various diseases. For this reason, antibacterial agents including various antibiotics are used to target these diseases, but some of these are also used for human diseases, and there is a problem of resistant bacteria. When you think about it, it's not necessarily a good idea. Kasugamycin is a drug developed as a rice blast control agent.Currently, it is widely used as a rice blast control agent, and its toxicity is extremely low.
No chronic toxicity was observed. Furthermore, it has been confirmed that kasugamycin is excreted relatively quickly in animal bodies and decomposed in the natural environment, making it an extremely safe drug. In addition, the half-lethal concentration of kasugamycin hydrochloride for aquatic animals other than yellowtail is 1000 ppm or more for carp, wakin, Japanese medaka, Japanese locust, tadpole, daphnia, and water flea, indicating extremely low fish toxicity. for that,
Even if a relatively high concentration of chemical treatment is performed, there is no risk of contamination or death of these aquatic animals due to wastewater containing the chemical, and the desired therapeutic effect can be achieved without causing chemical damage to yellowtail. I can give you enough. Using the commonly used agar dilution method, we determined the minimum inhibitory concentration of kasugamycin against bacteria that infect yellowtail. The results are shown in Table 1.

【表】【table】

【表】 カスガマイシンを用いてハマチの細菌性疾病を
治療する方法としては、カスガマイシン単独の薬
液中にハマチを薬浴せしめるか、または池あるい
はその他の槽中に一定濃度になるように溶解して
用いればよく、さらにニトロフラン系薬剤などの
他の薬剤と併用することもできる。またカスガマ
イシンを飼料中に混合して経口投与することもで
きる。
[Table] Kasugamycin can be used to treat bacterial diseases in yellowtail by bathing yellowtail in a chemical solution containing kasugamycin alone, or by dissolving it in a pond or other tank to a certain concentration. Furthermore, it can be used in combination with other drugs such as nitrofurans. Kasugamycin can also be mixed into feed and administered orally.

Claims (1)

【特許請求の範囲】[Claims] 1 カスガマイシンまたはその塩類を有効成分と
して含有することを特徴とするハマチの細菌性疾
病防除剤。
1. A bacterial disease control agent for yellowtail, characterized by containing kasugamycin or its salts as an active ingredient.
JP8824886A 1986-04-18 1986-04-18 Agent for controlling bacterial disease of young yellowtall Granted JPS61275219A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8824886A JPS61275219A (en) 1986-04-18 1986-04-18 Agent for controlling bacterial disease of young yellowtall

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8824886A JPS61275219A (en) 1986-04-18 1986-04-18 Agent for controlling bacterial disease of young yellowtall

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP13843376A Division JPS5366441A (en) 1976-11-19 1976-11-19 Antibacterial agent for fish

Publications (2)

Publication Number Publication Date
JPS61275219A JPS61275219A (en) 1986-12-05
JPH0133447B2 true JPH0133447B2 (en) 1989-07-13

Family

ID=13937550

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8824886A Granted JPS61275219A (en) 1986-04-18 1986-04-18 Agent for controlling bacterial disease of young yellowtall

Country Status (1)

Country Link
JP (1) JPS61275219A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5366441A (en) * 1976-11-19 1978-06-13 Hokko Chem Ind Co Ltd Antibacterial agent for fish

Also Published As

Publication number Publication date
JPS61275219A (en) 1986-12-05

Similar Documents

Publication Publication Date Title
Klinger et al. Introduction to freshwater fish parasites
Burka et al. Drugs in salmonid aquaculture–a review
WO2007122619B1 (en) Tto-based wide spectrum therapeutics, disinfectants & anesthetics for use in aquaculture
Hadfield et al. Amphibian emergency medicine and care
Stoffregen et al. Antibacterial chemotherapeutants for finfish aquaculture: a synopsis of laboratory and field efficacy and safety studies
KR101817817B1 (en) Fish parasite extermination agent and extermination method
Tonguthai Control of freshwater fish parasites: a Southeast Asian perspective
Banu et al. Myxozoan fish diseases: possible treatment and zoonoses
He et al. Experimental evidence of effective disinfectant to control the transmission of Micropterus salmoides rhabdovirus
Lunestad et al. Veterinary drug use in aquaculture
Sundberg et al. Cryptosporidiosis in a gray squirrel
SPAETH et al. Treatment of trichinosis: case report
JPH0133447B2 (en)
KR101544049B1 (en) Compositions for preventing and curing Scuticocilliatosis scutica in a cultivated flounder
Wildgoose et al. Therapeutics
JPH0132209B2 (en)
RU2147237C1 (en) Preparation for treatment of calves with colibacteriosis and method of its using
JPS6137251B2 (en)
Phelps et al. Control of external bacterial infections of bluegills with potassium permanganate
Walker et al. Amphibian therapeutics
RU2058779C1 (en) Composition for prophylaxis and treatment of gastroenteric disease in agriculture animals
RU2808519C1 (en) Means for control of fish diseases
RU2228171C2 (en) Method for treating overall dyspepsias in neonatal calves with sodium acetate
JP2008535901A (en) Treatment of human and animal parasitic infections
KR100358084B1 (en) Treatment of gill monogenean disease in fish using praziquantel and cimetidine